ENTRY       K04234                      KO
NAME        F2RL1, PAR2
DEFINITION  coagulation factor II (thrombin) receptor-like 1
PATHWAY     ko04080  Neuroactive ligand-receptor interaction
            ko04750  Inflammatory mediator regulation of TRP channels
            ko05143  African trypanosomiasis
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signaling molecules and interaction
               04080 Neuroactive ligand-receptor interaction
                K04234  F2RL1, PAR2; coagulation factor II (thrombin) receptor-like 1
             Organismal Systems
              Sensory system
               04750 Inflammatory mediator regulation of TRP channels
                K04234  F2RL1, PAR2; coagulation factor II (thrombin) receptor-like 1
             Human Diseases
              Infectious diseases
               05143 African trypanosomiasis
                K04234  F2RL1, PAR2; coagulation factor II (thrombin) receptor-like 1
            G protein-coupled receptors [BR:ko04030]
             Class A. Rhodopsin family
              Complement peptide
               Thrombin
                K04234  F2RL1, PAR2; coagulation factor II (thrombin) receptor-like 1
GENES       HSA: 2150(F2RL1)
            PTR: 461800(F2RL1)
            PPS: 100985711(F2RL1)
            GGO: 101146046(F2RL1)
            PON: 100448764(F2RL1)
            MCC: 707479(F2RL1)
            MCF: 102137513(F2RL1)
            MMU: 14063(F2rl1)
            RNO: 116677(F2rl1)
            CGE: 100757860(F2rl1)
            HGL: 101708898(F2rl1) 101718058 101728631
            TUP: 102485462(F2RL1)
            CFA: 488940(F2RL1)
            AML: 100483212(F2RL1)
            FCA: 101082879(F2RL1)
            PTG: 102960149(F2RL1)
            BTA: 526525(F2RL1)
            BOM: 102271773(F2RL1)
            PHD: 102325378(F2RL1)
            CHX: 102187771(F2RL1)
            SSC: 100519703(F2RL1)
            CFR: 102520615(F2RL1)
            BACU: 103006000(F2RL1)
            LVE: 103077744(F2RL1)
            ECB: 100073277(F2RL1)
            MYB: 102249464(F2RL1)
            MYD: 102755239(F2RL1)
            PALE: 102892595(F2RL1)
            MDO: 100010197(F2RL1)
            SHR: 100934491(F2RL1)
            OAA: 100083214
            GGA: 427213(F2RL1)
            MGP: 100543031
            TGU: 100226444(F2RL1)
            FAB: 101815040(F2RL1)
            PHI: 102110361(F2RL1)
            APLA: 101791388(F2RL1)
            FPG: 101917674 101917800(F2RL1)
            FCH: 102054895 102055035(F2RL1)
            CLV: 102096314(F2RL1)
            ASN: 102373577(F2RL1)
            AMJ: 102559405(F2RL1)
            PSS: 102452058(F2RL1)
            CMY: 102932670(F2RL1)
            PBI: 103057121(F2RL1)
            XLA: 496315(f2rl1) 496339(par2)
            XTR: 100135248(f2rl1) 100490447(f2rl1)
            DRE: 100073342(f2rl1.2) 794649(f2rl1.1)
            TRU: 101064847 101078077
            MZE: 101482080 101482375
            OLA: 101167884 101174360
            XMA: 102220423 102228546
            LCM: 102350347 102354930 102355201
            CMK: 103186384(f2rl1)
REFERENCE   PMID:16714334
  AUTHORS   Winter MC, Shasby SS, Ries DR, Shasby DM
  TITLE     PAR2 activation interrupts E-cadherin adhesion and compromises the airway epithelial barrier: protective effect of beta-agonists.
  JOURNAL   Am J Physiol Lung Cell Mol Physiol 291:L628-35 (2006)
///
